Olink : Biomarkers of drug action in phase 2 studies of Povo

Olink : Biomarkers of drug action in phase 2 studies of Povorcitinib

Share

share on facebook

share on twitter
... | May 12, 2023

Related Keywords

, Incyte Corporation Wilmington , Incyte Corporation , Janus Kinase , Hidradenitis Suppurativa , Olink Holding Ab Publ Stock Exchange , News , Information , Press Release , Phare , N , N Olk Us6807101000 ,